Discovery of a PROTAC degrader for METTL3-METTL14 complex

Wenhao Du,Yuting Huang,Xiaoai Chen,Yue Deng,Yaoliang Sun,Hong Yang,Qiongyu Shi,Feifei Wu,Guobin Liu,He Huang,Jian Ding,Xun Huang,Shilin Xu

DOI: https://doi.org/10.1016/j.chembiol.2023.12.009

IF: 9.039

2024-01-01

Cell Chemical Biology

Abstract:N⁶-methyladenosine (m⁶A) methylation is the most abundant type of RNA modification that is mainly catalyzed by the METTL3-METTL14 methyltransferase complex. This complex has been linked to multiple cancers and is considered a promising therapeutic target for acute myeloid leukemia (AML). However, only a few METTL3 inhibitors targeting the catalytic activity were developed recently. Here, we present the discovery of WD6305 as the potent and selective proteolysis-targeting chimera (PROTAC) degrader of METTL3-METTL14 complex. WD6305 suppresses m⁶A modification and the proliferation of AML cells, and promotes apoptosis much more effectively than its parent inhibitor. WD6305 also affects a variety of signaling pathways related to the development and proliferation of AML. Collectively, our study reveals PROTAC degradation of METTL3-METTL14 complex as a potential anti-leukemic strategy and provides desirable chemical tool for further understanding METTL3-METTL14 protein functions.

biochemistry & molecular biology